Furthermore, UTMD‐mediated BMP9 delivery restored the anti‐tumour function of NK cells administered in combination with a PD‐L1 inhibitor to suppress tumour growth in an HBV‐infected HCC xenograft model. This evidence concerns the gene GDF2 and hepatocellular carcinoma.